Clinical Trial Update: Qishenyiqi for Ventricular Remodeling After Myocardial Infarction [Phase 4]

View source ↗

Summary

Phase 4 study evaluating Qishenyiqi for ventricular remodeling after myocardial infarction is not yet recruiting in patients with chronic stable heart failure. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• Qishenyiqi

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Chronic Stable Heart Failure | Phase 4 | Status: NOT_YET_RECRUITING